Follow the people · Insider
Howard G. Welgus
Howard G. Welgus files insider transactions with the SEC as a chief medical officer of Arcutis Biotherapeutics (ARQT). We hold 9 disclosed purchases and sales filed since 4 February 2020, 4 of them in the last 90 days.
- Files forARQT
- Disclosed buys and sells9 in all, 4 in the last 90 days
- Last disclosure19 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 4 February 2020 — 17 August 2026Chief Medical Officer · Arcutis Biotherapeutics (ARQT)263 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 822 shares of Arcutis BiotherapeuticsSEC Form 419 August 2026Common Stock · traded 17 August 2026 · filed 19 August 2026
- exercised options over 1,019 shares of Arcutis BiotherapeuticsSEC Form 419 August 2026Common Stock · traded 17 August 2026 · filed 19 August 2026
- exercised options over 2,255 shares of Arcutis BiotherapeuticsSEC Form 419 August 2026Common Stock · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 4,730 shares of Arcutis BiotherapeuticsSEC Form 419 August 2026Common Stock · traded 17 August 2026 · filed 19 August 2026
- exercised options over 822 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 419 August 2026Stock Option (right to buy) · traded 17 August 2026 · filed 19 August 2026
- exercised options over 1,019 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 419 August 2026Stock Option (right to buy) · traded 17 August 2026 · filed 19 August 2026
- exercised options over 2,255 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 419 August 2026Stock Option (right to buy) · traded 17 August 2026 · filed 19 August 2026
- exercised options over 822 shares of Arcutis BiotherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 1,019 shares of Arcutis BiotherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 2,255 shares of Arcutis BiotherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 4,730 shares of Arcutis BiotherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 822 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 July 2026Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 1,019 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 July 2026Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 2,255 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 July 2026Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 822 shares of Arcutis BiotherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- exercised options over 1,019 shares of Arcutis BiotherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- exercised options over 2,255 shares of Arcutis BiotherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 4,096 shares of Arcutis BiotherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 635 shares of Arcutis BiotherapeuticsSEC Form 417 June 2026Common Stock · traded 17 June 2026 · filed 17 June 2026
- exercised options over 822 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 June 2026Stock Option (right to buy) · traded 15 June 2026 · filed 17 June 2026
- exercised options over 1,019 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 June 2026Stock Option (right to buy) · traded 15 June 2026 · filed 17 June 2026
- exercised options over 2,255 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 June 2026Stock Option (right to buy) · traded 15 June 2026 · filed 17 June 2026
- was granted 5,778 shares of Arcutis BiotherapeuticsSEC Form 49 June 2026Common Stock · traded 5 June 2026 · filed 9 June 2026
- was granted 16,667 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 49 June 2026Stock Option (right to buy) · traded 5 June 2026 · filed 9 June 2026
- ▼ sold on the open market 7,144 shares of Arcutis BiotherapeuticsSEC Form 45 May 2026Common Stock · traded 1 May 2026 · filed 5 May 2026
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 43 December 2025Common Stock · traded 1 December 2025 · filed 3 December 2025
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- exercised options over 9,538 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 43 October 2025Stock Option (right to buy) · traded 1 October 2025 · filed 3 October 2025
- exercised options over 9,538 shares of Arcutis BiotherapeuticsSEC Form 43 October 2025Common Stock · traded 1 October 2025 · filed 3 October 2025
- ▼ sold on the open market 9,538 shares of Arcutis BiotherapeuticsSEC Form 43 October 2025Common Stock · traded 1 October 2025 · filed 3 October 2025
- ▼ sold on the open market 462 shares of Arcutis BiotherapeuticsSEC Form 43 October 2025Common Stock · traded 1 October 2025 · filed 3 October 2025
- exercised options over 10,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 44 September 2025Stock Option (right to buy) · traded 2 September 2025 · filed 4 September 2025
- exercised options over 10,000 shares of Arcutis BiotherapeuticsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- exercised options over 6,110 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 45 August 2025Stock Option (right to buy) · traded 1 August 2025 · filed 5 August 2025
- exercised options over 3,890 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 45 August 2025Stock Option (right to buy) · traded 1 August 2025 · filed 5 August 2025
- exercised options over 6,110 shares of Arcutis BiotherapeuticsSEC Form 45 August 2025Common Stock · traded 1 August 2025 · filed 5 August 2025
- ▼ sold on the open market 6,110 shares of Arcutis BiotherapeuticsSEC Form 45 August 2025Common Stock · traded 1 August 2025 · filed 5 August 2025
- exercised options over 3,890 shares of Arcutis BiotherapeuticsSEC Form 45 August 2025Common Stock · traded 1 August 2025 · filed 5 August 2025
- ▼ sold on the open market 3,890 shares of Arcutis BiotherapeuticsSEC Form 45 August 2025Common Stock · traded 1 August 2025 · filed 5 August 2025
- ▼ sold on the open market 9,208 shares of Arcutis BiotherapeuticsSEC Form 42 July 2025Common Stock · traded 1 July 2025 · filed 2 July 2025
- ▼ sold on the open market 10,139 shares of Arcutis BiotherapeuticsSEC Form 420 June 2025Common Stock · traded 18 June 2025 · filed 20 June 2025
- was granted 20,568 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 416 June 2025Stock Option (right to buy) · traded 12 June 2025 · filed 16 June 2025
- was granted 7,609 shares of Arcutis BiotherapeuticsSEC Form 416 June 2025Common Stock · traded 12 June 2025 · filed 16 June 2025
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 45 May 2025Common Stock · traded 1 May 2025 · filed 5 May 2025
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 43 April 2025Common Stock · traded 1 April 2025 · filed 3 April 2025
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 44 March 2025Common Stock · traded 3 March 2025 · filed 4 March 2025
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 44 February 2025Common Stock · traded 3 February 2025 · filed 4 February 2025
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 46 January 2025Common Stock · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 45 November 2024Common Stock · traded 1 November 2024 · filed 5 November 2024
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- exercised options over 6,614 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 45 August 2024Stock Option (right to buy) · traded 1 August 2024 · filed 5 August 2024
- exercised options over 6,614 shares of Arcutis BiotherapeuticsSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- ▼ sold on the open market 6,614 shares of Arcutis BiotherapeuticsSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- ▼ sold on the open market 3,386 shares of Arcutis BiotherapeuticsSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- exercised options over 5,681 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 42 July 2024Stock Option (right to buy) · traded 1 July 2024 · filed 2 July 2024
- exercised options over 4,319 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 42 July 2024Stock Option (right to buy) · traded 1 July 2024 · filed 2 July 2024
- exercised options over 5,681 shares of Arcutis BiotherapeuticsSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- exercised options over 4,319 shares of Arcutis BiotherapeuticsSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- ▼ sold on the open market 10,000 shares of Arcutis BiotherapeuticsSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- was granted 27,052 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 418 June 2024Stock Option (right to buy) · traded 14 June 2024 · filed 18 June 2024
- was granted 10,139 shares of Arcutis BiotherapeuticsSEC Form 418 June 2024Common Stock · traded 14 June 2024 · filed 18 June 2024
- exercised options over 3,542 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 46 June 2024Stock Option (right to buy) · traded 4 June 2024 · filed 6 June 2024
- exercised options over 6,458 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 46 June 2024Stock Option (right to buy) · traded 4 June 2024 · filed 6 June 2024
- exercised options over 3,542 shares of Arcutis BiotherapeuticsSEC Form 46 June 2024Common Stock · traded 4 June 2024 · filed 6 June 2024
- exercised options over 6,458 shares of Arcutis BiotherapeuticsSEC Form 46 June 2024Common Stock · traded 4 June 2024 · filed 6 June 2024
- ▼ sold on the open market 3,542 shares of Arcutis BiotherapeuticsSEC Form 46 June 2024Common Stock · traded 4 June 2024 · filed 6 June 2024
- ▼ sold on the open market 6,458 shares of Arcutis BiotherapeuticsSEC Form 46 June 2024Common Stock · traded 4 June 2024 · filed 6 June 2024
- was granted 12,220 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 42 June 2023Stock Option (right to buy) · traded 31 May 2023 · filed 2 June 2023
- was granted 4,375 shares of Arcutis BiotherapeuticsSEC Form 42 June 2023Common Stock · traded 31 May 2023 · filed 2 June 2023
- exercised options over 8,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 418 April 2023Stock Option (right to buy) · traded 17 April 2023 · filed 18 April 2023
- exercised options over 8,500 shares of Arcutis BiotherapeuticsSEC Form 418 April 2023Common Stock · traded 17 April 2023 · filed 18 April 2023
- ▼ sold on the open market 8,500 shares of Arcutis BiotherapeuticsSEC Form 418 April 2023Common Stock · traded 17 April 2023 · filed 18 April 2023
- exercised options over 8,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 410 April 2023Stock Option (right to buy) · traded 6 April 2023 · filed 10 April 2023
- exercised options over 8,500 shares of Arcutis BiotherapeuticsSEC Form 410 April 2023Common Stock · traded 6 April 2023 · filed 10 April 2023
- ▼ sold on the open market 8,500 shares of Arcutis BiotherapeuticsSEC Form 410 April 2023Common Stock · traded 6 April 2023 · filed 10 April 2023
- exercised options over 8,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 421 February 2023Stock Option (right to buy) · traded 15 February 2023 · filed 21 February 2023
- exercised options over 8,500 shares of Arcutis BiotherapeuticsSEC Form 421 February 2023Common Stock · traded 15 February 2023 · filed 21 February 2023
- ▼ sold on the open market 8,500 shares of Arcutis BiotherapeuticsSEC Form 421 February 2023Common Stock · traded 15 February 2023 · filed 21 February 2023
- exercised options over 8,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 418 January 2023Stock Option (right to buy) · traded 17 January 2023 · filed 18 January 2023
- exercised options over 8,500 shares of Arcutis BiotherapeuticsSEC Form 418 January 2023Common Stock · traded 17 January 2023 · filed 18 January 2023
- ▼ sold on the open market 8,500 shares of Arcutis BiotherapeuticsSEC Form 418 January 2023Common Stock · traded 17 January 2023 · filed 18 January 2023
- exercised options over 1,020 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 November 2022Stock Option (right to buy) · traded 15 November 2022 · filed 17 November 2022
- exercised options over 1,020 shares of Arcutis BiotherapeuticsSEC Form 417 November 2022Common Stock · traded 15 November 2022 · filed 17 November 2022
- ▼ sold on the open market 3,403 shares of Arcutis BiotherapeuticsSEC Form 417 November 2022Common Stock · traded 15 November 2022 · filed 17 November 2022
- ▼ sold on the open market 6,000 shares of Arcutis BiotherapeuticsSEC Form 46 October 2022Common Stock · traded 4 October 2022 · filed 6 October 2022
- ▼ sold on the open market 6,000 shares of Arcutis BiotherapeuticsSEC Form 417 August 2022Common Stock · traded 15 August 2022 · filed 17 August 2022
- ▼ sold on the open market 6,000 shares of Arcutis BiotherapeuticsSEC Form 418 July 2022Common Stock · traded 18 July 2022 · filed 18 July 2022
- was granted 11,796 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 43 June 2022Stock Option (Right to Buy) · traded 1 June 2022 · filed 3 June 2022
- was granted 4,312 shares of Arcutis BiotherapeuticsSEC Form 43 June 2022Common Stock · traded 1 June 2022 · filed 3 June 2022
- exercised options over 2,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 42 June 2022Stock Option (Right to Buy) · traded 1 June 2022 · filed 2 June 2022
- exercised options over 2,500 shares of Arcutis BiotherapeuticsSEC Form 42 June 2022Common Stock · traded 1 June 2022 · filed 2 June 2022
- ▼ sold on the open market 2,500 shares of Arcutis BiotherapeuticsSEC Form 42 June 2022Common Stock · traded 1 June 2022 · filed 2 June 2022
- exercised options over 1,496 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 43 May 2022Stock Option (Right to Buy) · traded 2 May 2022 · filed 3 May 2022
- exercised options over 1,004 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 43 May 2022Stock Option (Right to Buy) · traded 2 May 2022 · filed 3 May 2022
- exercised options over 1,496 shares of Arcutis BiotherapeuticsSEC Form 43 May 2022Common Stock · traded 2 May 2022 · filed 3 May 2022
- exercised options over 1,004 shares of Arcutis BiotherapeuticsSEC Form 43 May 2022Common Stock · traded 2 May 2022 · filed 3 May 2022
- ▼ sold on the open market 2,500 shares of Arcutis BiotherapeuticsSEC Form 43 May 2022Common Stock · traded 2 May 2022 · filed 3 May 2022
- exercised options over 7,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 41 April 2022Stock Option (Right to Buy) · traded 1 April 2022 · filed 1 April 2022
- exercised options over 7,500 shares of Arcutis BiotherapeuticsSEC Form 41 April 2022Common Stock · traded 1 April 2022 · filed 1 April 2022
- ▼ sold on the open market 7,500 shares of Arcutis BiotherapeuticsSEC Form 41 April 2022Common Stock · traded 1 April 2022 · filed 1 April 2022
- exercised options over 2,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 45 January 2022Stock Option (Right to Buy) · traded 3 January 2022 · filed 5 January 2022
- exercised options over 2,500 shares of Arcutis BiotherapeuticsSEC Form 45 January 2022Common Stock · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 2,500 shares of Arcutis BiotherapeuticsSEC Form 45 January 2022Common Stock · traded 3 January 2022 · filed 5 January 2022
- exercised options over 2,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 423 December 2021Stock Option (Right to Buy) · traded 23 December 2021 · filed 23 December 2021
- exercised options over 2,500 shares of Arcutis BiotherapeuticsSEC Form 423 December 2021Common Stock · traded 23 December 2021 · filed 23 December 2021
- ▼ sold on the open market 2,500 shares of Arcutis BiotherapeuticsSEC Form 423 December 2021Common Stock · traded 23 December 2021 · filed 23 December 2021
- exercised options over 2,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 43 November 2021Stock Option (Right to Buy) · traded 1 November 2021 · filed 3 November 2021
- exercised options over 2,500 shares of Arcutis BiotherapeuticsSEC Form 43 November 2021Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 2,500 shares of Arcutis BiotherapeuticsSEC Form 43 November 2021Common Stock · traded 1 November 2021 · filed 3 November 2021
- exercised options over 2,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 45 October 2021Stock Option (Right to Buy) · traded 1 October 2021 · filed 5 October 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.